Fig. 4: Biocompatibility assessment of BisGMA and BGPGMA precursors, monomers, and composites.
From: Lignin-derived bisguaiacol P vinyl ester as a bisphenol A-free resin alternative
a EC50 of BGP- and BPA-based bisphenols/guaiacols, epoxides, and monomers, as assessed by the LDH and XTT assays. b TailDNA% as assessed by comet assay. Data are presented as mean ± standard deviation (SD) of medians of cells scored per test condition per replicate; *indicates statistical significance at p < 0.05; **indicates statistical significance at p < 0.01 (One-Way ANOVA, post-hoc Tukey’s) (n = 3; in triplicate). c Computed logP. d Relative cell viability (mean% ± SD) after exposure to eluates from BGPGMACOMP, BisGMACOMP, and MajestyCOMP composites.
